Monomeric agonist peptide/ MHCII complexes activate T‐cells in an autonomous fashion
EMBO reports · 2023
DOI: 10.15252/embr.202357842 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO reports, 2023. Verfasst von René Platzer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pathophysiology, Infectiology, Immunology, Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: T-Lymphocytes, Histocompatibility Antigens Class II. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund, Boehringer Ingelheim Fonds.
Abstract (Originalsprache)
Molecular crowding of agonist peptide/MHC class II complexes (pMHCIIs) with structurally similar, yet per se non‐stimulatory endogenous pMHCIIs is postulated to sensitize T‐cells for the recognition of single antigens on the surface of dendritic cells and B‐cells. When testing this premise with the use of advanced live cell microscopy, we observe pMHCIIs as monomeric, randomly distributed entities diffusing rapidly after entering the APC surface. Synaptic TCR engagement of highly abundant endogenous pMHCIIs is low or non‐existent and affects neither TCR engagement of rare agonist pMHCII in early and advanced synapses nor agonist‐induced TCR‐proximal signaling. Our findings highlight the capacity of single freely diffusing agonist pMHCIIs to elicit the full T‐cell response in an autonomous and peptide‐specific fashion with consequences for adaptive immunity and immunotherapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pathophysiology, Infectiology, Immunology, Institute for Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria.
- TU Wien, Institute of Applied Physics, Vienna, Austria.
- Center for Pathophysiology, Infectiology, Immunology, Institute for Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Joschka Hellmeier, Janett Göhring, Clara Bodner, Margarete Focke-Tejkl, Hannes Stockinger, Mario Brameshuber, Johannes B Huppa
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
- Boehringer Ingelheim Fonds
- Vienna Science and Technology Fund
Zitieren
APA
Platzer, R., Hellmeier, J., Göhring, J., Perez, I. D., Schatzlmaier, P., Bodner, C., Focke-Tejkl, M., Schütz, G. J., Sevcsik, E., Stockinger, H., Brameshuber, M., & Huppa, J. B. (2023). Monomeric agonist peptide/ MHCII complexes activate T‐cells in an autonomous fashion. EMBO reports. https://doi.org/10.15252/embr.202357842
Vancouver
Platzer R, Hellmeier J, Göhring J, Perez ID, Schatzlmaier P, Bodner C, et al. Monomeric agonist peptide/ MHCII complexes activate T‐cells in an autonomous fashion. EMBO reports. 2023. doi:10.15252/embr.202357842
BibTeX
@article{Platzer2023,
author = {Platzer, René and Hellmeier, Joschka and Göhring, Janett and Perez, Iago Doel and Schatzlmaier, Philipp and Bodner, Clara and Focke-Tejkl, Margarete and Schütz, Gerhard J and Sevcsik, Eva and Stockinger, Hannes and Brameshuber, Mario and Huppa, Johannes B},
title = {Monomeric agonist peptide/ MHCII complexes activate T‐cells in an autonomous fashion},
journal = {EMBO reports},
year = {2023},
doi = {10.15252/embr.202357842}
}
EUVIMED